Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Comparative Proximate Composition and Hypoglycemic Properties of Three Medicinal Plants (Verononia amygdalina, Azadirachta indica and Moringa oleifera)

    wadmin2By wadmin2May 26, 2014Updated:August 10, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Ojiako, A.Okey1 and Chikezie and Paul Chidoka2
    1Department of Biochemistry, Federal University of Technology, Owerri, Nigeria.
    2Department of Biochemistry, Imo State University, Owerri, Nigeria.

    Pharmacognosy Communications,2014,4,3,40-48.
    DOI:10.5530/pc.2014.3.4
    Published:May 2014
    Type:Original Article

    ABSTRACT

    The present study sought to investigate proximate composition in relation to the short and long term hypoglycemic effects of ethanol/water leaf extracts of Verononia amygdalina, Azadirachta indica and Moringa oleifera on hyperglycemic rats. Hyperglycemia was induced by a single intra-peritoneal injection of 0.1 mol/L alloxan monohydrate in phosphate buffer saline (PBS) solution (pH =7.4) dosage = 140 mg/kg; b/w. Individual hyperglycemic rats received separate doses of either 400 mg/kg bw/12 h of V. amygdalina, A. indica or M. oleifera for 14 days. Blood samples were drawn from the rats at regular intervals of 12 h for 48h duration; for short-term study, and subsequently, on days 3, 7, 10 and 14; for long term study, and measured for fasting blood glucose (FBG). Determination of FBG was by the glucose oxidase method. V. amygdalina, A. indica and M. oleifera showed wide variation in crude protein content (CPC), which was within the range of 13.42–37.01%. Total carbohydrate content (TCC) of V. amygdalina and A. indica was the single highest component with values: TCCV. amygdalina = 40.65% and TCC A. indica = 50.14%. In contrast, the CPC content was higher than theTCC contentfor M. oleifera (TCC M. oleifera = 36.65%; CPC M. oleifera = 37.01%). The administration of V. amygdalina, A. indica and M. oleifera to the rats (0 h β€œ t β€œ 48 h) did not cause significant (p > 0.05) reduction in FBG of hyperglycemic rats compared to the control group. Conversely, the administration of the three leaf extracts caused reduction in FBG in a time dependent manner in the order: H[M. oleifera] = 400 mg/kg; bw = 2.73 folds >H[V. amygdalina] = 400 mg/kg; bw = 2.15 folds >H[A. indica] = 400 mg/kg; bw = 1.75 folds; p < 0.05. Comparative proximate composition of V. amygdalina, A. indica and M. oleifera and corresponding capacity of the three leaf extracts to reduce FBG appears to suggest that biomolecules responsible for promoting FBG lowering effects are for the most part the TCC and CPC elements.

    Keywords: Proximate composition, fasting blood glucose, Verononia amygdalina, Azadirachta indica and Moringa oleifera.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up